Replies to post #13538 on GTC Biotherapeutics (fka GTCB)

[stockdak]

>The only substantial risk in an FoB deal is political: Will Congress adopt legislation that allows the FDA to approve generic versions of biologics?

I agree. I had believed that in spite of the election this year Congress would pass FoB legislation. The last that I had read showed promise in the early spring but now seems to have stalled as summer break is here. Do you still think legislation will be enacted in 08?

T.I.A.